Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Change in Acquisitions & Divestments (2016)

Phio Pharmaceuticals' Change in Acquisitions & Divestments history spans 4 years, with the latest figure at $2.0 million for Q4 2016.

  • For Q4 2016, Change in Acquisitions & Divestments changed N/A year-over-year to $2.0 million; the TTM value through Dec 2016 reached $7.5 million, changed N/A, while the annual FY2016 figure was $7.5 million, 200.0% up from the prior year.
  • Change in Acquisitions & Divestments reached $2.0 million in Q4 2016 per PHIO's latest filing, down from $3.5 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $43.5 million in Q4 2013 to a low of -$40.5 million in Q2 2014.
  • Average Change in Acquisitions & Divestments over 4 years is $24.3 million, with a median of $37.5 million recorded in 2012.
  • Peak YoY movement for Change in Acquisitions & Divestments: rose 16.0% in 2013, then tumbled 208.0% in 2014.
  • A 4-year view of Change in Acquisitions & Divestments shows it stood at $37.5 million in 2012, then increased by 16.0% to $43.5 million in 2013, then plummeted by 193.1% to -$40.5 million in 2014, then skyrocketed by 104.94% to $2.0 million in 2016.
  • Per Business Quant, the three most recent readings for PHIO's Change in Acquisitions & Divestments are $2.0 million (Q4 2016), $3.5 million (Q2 2016), and $2.0 million (Q1 2016).